Evaluation of the efficacy of ginger in reduction chemotherapy-induced nausea and vomiting in newly diagnosed breast cancer patients receiving doxorubicin(adriamycin)-based chemotherapy.
Phase 3
- Conditions
- Breast cancer.Breast, unspecified
- Registration Number
- IRCT2014050517581N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 110
Inclusion Criteria
New diagnosed breast cancer ;All ages ;Female ;No previous chemotherapy ;Prescription of doxorubicin-based chemotherapy ;No gastrointestinal obstruction ;No coagulopathy ;Receiving of standard anti-emetic treatment ;Completion of ethic form ;No concurrent hormontherapy or radiotherapy.
Exclusion criteria:
Bleeding ;Development of gastrointestinal obstruction ;Uncompleted questionnaires ;Less than 3 cycle doxorubicin-based chemotherapy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea severity and duration. Timepoint: 3-days. Method of measurement: questionnaire.;Vomiting frequency and duration. Timepoint: 3-days. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Coagulation disorders. Timepoint: 3-weeks. Method of measurement: questionnaire.;Gastrointestinal disorders. Timepoint: 3-weeks. Method of measurement: questionnaire.